FDA Approved: AMBRISENTAN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ambrisentan submitted by Sun Pharmaceutical Industries, Inc. The action concerns an update to the product's appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• LETAIRIS (ambrisentan)

Snippet

SUPPL AP for AMBRISENTAN (AMBRISENTAN)